How is acute bronchopneumonia treated?
Acute bronchopneumonia is typically managed with both symptomatic and etiologic (causative) therapies. For symptoms such as cough, sputum production, chest tightness, and shortness of breath, appropriate symptomatic medications—including antitussives and expectorants—may be prescribed. Examples include ambroxol–clenbuterol oral solution, compound promethazine syrup, Qingfei Huatan Zhike Granules (a traditional Chinese medicine formulation for clearing lung heat, resolving phlegm, and relieving cough), carboxymethylcysteine oral solution, and ambroxol syrup.

Inhalation therapy via nebulization may also be employed, using budesonide nebulizer solution and chymotrypsin. For pathogen-directed treatment—particularly against bacterial infection—antibiotics such as amoxicillin–clavulanate potassium, cefoperazone sodium–sulbactam sodium, ceftriaxone sodium, azithromycin, clindamycin, or levofloxacin may be selected.

In most cases, intravenous infusion is the preferred route of administration, with a typical course lasting approximately one week. The treatment plan should be adjusted promptly based on diagnostic test results and disease severity.

Acute bronchitis is an inflammatory condition of the bronchial mucosa caused by pathogens—including viruses or bacteria—and is a common and frequently occurring disease in infants and young children. It often develops following upper respiratory tract infections and may represent an early stage of pneumonia.